 |
 |
 |
 |
 |
 |
 |
 |
 |
Salmedix, Inc.
Salmedix was a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. Easton invested in Salmedix in March 2004, and Salmedix was acquired in June 2005, providing Easton with proceeds approximately twice its investment.